Procept Biorobotics saw no growth in patent filings and highest growth of 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Procept Biorobotics‘s patent filings and grants. Buy the databook here.
Procept Biorobotics has been focused on protecting inventions in European Patent Office(EPO) with two publications in Q2 2024
The United States(US), World Intellectual Property Organization(WIPO), and European Patent Office(EPO) patent Office are among the top ten patent offices where Procept Biorobotics is filings its patents. Among the top granted patent authorities, Procept Biorobotics has 100% of its grants in United States(US).
Thermedical and Boston Scientific could be the strongest competitors for Procept Biorobotics
Patents related to swarm technologies and healthtech lead Procept Biorobotics's portfolio
Procept Biorobotics has the highest number of patents in swarm technologies followed by, healthtech and remote patient monitoring. For swarm technologies no patents were filed and 12% of patents were granted in Q2 2024.
Diagnostic imaging related patents lead Procept Biorobotics portfolio followed by general surgery devices, and autonomous driving
Procept Biorobotics has highest number of patents in diagnostic imaging followed by general surgery devices, autonomous driving, robotic surgery, and healthcare it. For diagnostic imaging, nearly 100% of patents were filed and 11% of patents were granted in Q2 2024.
For comprehensive analysis of Procept Biorobotics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.